You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm said it has developed a POC test that uses a biomarker for HPV16, which is responsible for more than 90 percent of all HPV-related head and neck tumors.
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
Linear Diagnostics, which recently raised £800,000, is also seeking partners to help it market its test platform worldwide.
The group is developing a test that uses a spectroscopic technique called surface-enhanced Raman scattering to provide rapid results at the site of injury.
The test detects the presence of two biomarkers within a single cell associated with HPV infections that can progress to cervical cancer.
The LUNGevity Foundation and 41 stakeholders aim to reduce cancer patients' confusion about in vitro diagnostic testing by implementing two consistent umbrella terms.
Sienna said that Unilabs, a commercial lab in Sweden, is evaluating its hTERT bladder cancer test for routine use.
The company's adaptive low-resource testing technology requires no instrumentation and limited equipment, making it adaptable to settings without clinical lab infrastructure.
The company announced during its Q4 earnings call that it had acquired Paradigm Diagnostics and Viomics to fill out its expertise in cancer diagnostics.
The alliance will leverage Charleston, Veravas' sample prep technology and Tymora's extracellular vesicle enrichment technology.